Back to search
Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System trials you may qualify forThis phase I trial tests the safety, side effects, best dose and effectiveness of lenalidomide when added to nivolumab and the usual drugs (rituximab and methot…
This is an open-label, Phase 1/2 study designed to characterize the safety, tolerability, Pharmacokinetics(PK), and preliminary antitumor activity of AVM0703 ad…
DALY II USA is a phase II, multi-center, single arm study to evaluate the efficacy, safety, and pharmacokinetics of zamtocabtagene autoleucel (MB-CART2019.1) in…
Relapsed or refractory primary DLBCL of the CNS
This study is evaluating whether an experimental treatment called GLPG5101 helps to treat non-Hodgkin lymphoma (NHL) and if it is safe to use. This study will…
Background: People with primary diffuse large B-cell lymphoma of the central nervous system (CNS) and aggressive B-cell lymphomas with secondary CNS involvemen…